Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Osagie O Imasogie
AddedMar 31, 2024
UpdatedMay 31, 2026
Osagie O Imasogie

Osagie O Imasogie

Board Member, University City Science Center

Crunchbase

Osagie O Imasogie's Career

University City Science Center
University City Science Center

Philadelphia, PA, US

Board Member· Board
Zabecor Pharmaceuticals
Zabecor Pharmaceuticals

Bala Cynwyd, PA, US

Board Member· Board
Iroko Pharmaceuticals
Iroko Pharmaceuticals

Philadelphia, PA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Osagie O Imasogie's Career

University City Science Center
University City Science Center
Investment FirmInvestment Firm$3M1331963Philadelphia, PA, US
Board Member· Board

Leadership at University City Science Center

Christopher M. CashmanChristopher M. CashmanBoard Member
Jane H. HollingsworthJane H. HollingsworthBoard Member
Stephen SpinelliStephen SpinelliBoard Member
Paul TouheyPaul TouheyBoard Member
Steve ZarrilliSteve ZarrilliBoard Member
Richard JaffeRichard JaffeBoard Member

Similar to University City Science Center

Startup PHLStartup PHLPhiladelphia, PA, USest. 2012Startup PHLPhiladelphia, PA, US · est. 2012

StartUp PHL: A venture capital firm revitalizing Philadelphia through entrepreneurial collaboration.

Investment Firm5
Philly Startup LeadersPhilly Startup LeadersPhiladelphia, PA, USest. 2007Philly Startup LeadersPhiladelphia, PA, US · est. 2007

Philly Startup Leaders: A dynamic community connecting tech-focused startups with resources and inspiration.

Investment Firm17
Erie Innovation DistrictErie Innovation DistrictPennsylvania Furnace, PA, USest. 2017Erie Innovation DistrictPennsylvania Furnace, PA, US · est. 2017

Nonprofit tech marketplace & innovation hub, transforming Erie into a secure, resilient business environment.

Investment Firm5
ScienceScienceSanta Monica, CA, USest. 2011ScienceSanta Monica, CA, US · est. 2011

Science partners, developing and funding disruptive tech-based companies.

Investment Firm · $72.3M236
Zabecor Pharmaceuticals
Zabecor Pharmaceuticals
Angel$50k21992Bala Cynwyd, PA, US
Board Member· Board

Leadership at Zabecor Pharmaceuticals

Dr Alan D SchreiberDr Alan D SchreiberBoard Member
Alan SchreiberAlan SchreiberFounder

Similar to Zabecor Pharmaceuticals

Zai LabZai LabShanghai, Shanghai, CNPharmaceuticalsest. 2014Zai LabShanghai, Shanghai, CN · est. 2014

Zai Lab, a Shanghai-based biopharmaceutical company, develops and manufactures treatments for oncology, autoimmune, and infectious diseases globally.

Public · $1.7B2k
Iroko Pharmaceuticals
Iroko Pharmaceuticals
Acquired$215M02007Philadelphia, PA, US
Board Member· Board

Leadership at Iroko Pharmaceuticals

Pierre LegaultPierre LegaultBoard Member
Louis J. VollmerLouis J. VollmerCEO

Osagie O Imasogie's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Osagie O Imasogie

Ronald GoldRonald GoldBoard Member · NJ BioJohn CroweJohn CroweFounder & CEO · EIR PharmaceuticalsBryan LawlisBryan LawlisBoard Member · AbsciJohn FunkhouserJohn FunkhouserCEO · PharmaneticsRon CooperRon CooperBoard Member · Generation BioDaniel LynchDaniel LynchCEO · Ivrea Pharmaceuticals